Institution statistics

ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - Italy 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:600-700
Total Project Funding per Partner:800-900
Total Number of Projects:700-800
Networking Rank (Reputation):900-1000
Partner Constancy:300-400
Project Leadership Index:800-900
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:700-800
Diversity Index:600-700
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 36
As coordinator: 3
As participant: 31
Sole participant: 2
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 9.214.497 825.434 3
2016 0 13.136.218 1.522.500 2
2013 0 8.497.408 2.677.088 2
2012 0 16.979.480 307.205 3
2011 123.600 20.918.035 1.318.100 2 3
2010 0 8.998.890 306.554 2
2006 0 30.144.272 1.818.828 5
2005 76.632 1.987.708 195.990 1 2
2004 0 10.280.000 472.000 2
2003 0 1.288.036 64.379 2
2002 0 3.805.025 253.668 2
2001 970.640 1.587.543 334.641 1 1
2000 2.399.729 2.349.315 706.131 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
DEUTSCHES KREBSFORSCHUNGSZENTRUM7
KAROLINSKA INSTITUTE7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
INSTITUT GUSTAVE ROUSSY5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER4
KATHOLIEKE UNIVERSITEIT LEUVEN4
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
ACADEMISCH ZIEKENHUIS LEIDEN3
DANISH CANCER SOCIETY3
GERMAN CANCER RESEARCH CENTER3
INSTITUT CURIE3
MEDICAL RESEARCH COUNCIL3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA3
UNIVERSITAET BAYREUTH3
BRUNEL UNIVERSITY2
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG2
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG2
ECOLE NORMALE SUPERIEURE DE CACHAN2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA2
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT BERGONIE2
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL2
INSTITUTE OF ONCOLOGY LJUBLJANA2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
NATIONAL RESEARCH COUNCIL OF ITALY2
ST GEORGE'S HOSPITAL MEDICAL SCHOOL2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC2
TECHNOLOGICAL EDUCATIONAL INSTITUTE OF CRETE2
THE CHRISTIE NHS FOUNDATION TRUST2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF MILANO2
TTOPSTART BV2
UNIVERSITA DEGLI STUDI DI FIRENZE2
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II2
UNIVERSITA DEGLI STUDI DI PARMA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE CLAUDE BERNARD LYON 12
UNIVERSITE JOSEPH FOURIER GRENOBLE 12
UNIVERSITEIT GENT2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF AARHUS2
UNIVERSITY OF BRISTOL2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEICESTER2
AALBORG HOSPITAL1
ACATRIS HOLDING BV1
AGRICULTURAL RESEARCH DEPARTMENT1
ALLGEMEINES KRANKENHAUS ST GEORG1
ALLINIMAGE1
ANDALUSIAN SCHOOL OF PUBLIC HEALTH1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ARTTIC1
ASOCIACION INSTITUTO BIODONOSTIA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA1
ASSOCIAZIONE IBLEA PER LA RICERCA EPIDEMIOLOGICA ONLUS1
ASTON UNIVERSITY1
ATHENS TECHNOLOGY CENTER1
AUREUS PHARMA1
AUTONOMOUS UNIVERSITY OF BARCELONA1
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA1
AZIENDA SANITARIA REGIONALE1
BELFAST CITY HOSPITAL TRUST1
BENDER MEDSYSTEMS1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOELF1
BRAINSHAKE OY1
CAMBRIDGE PROTEIN ARRAYS1
CANCER RESEARCH UK1
CANISIUS WILHELMINA ZIEKENHUIS1
CAPSULUTION NANOSCIENCE1
CATALAN INSTITUTE OF ONCOLOGY1
CELLGENIX TECHNOLOGIE TRANSFER1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE HOSPITALO UNIVERSITAIRE SAINT LOUIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO PER LO STUDIO E LA PREVENZIONE ONCOLOGICA1
CENTRUM ONKOLOGII INSTYTUT IM MARII SKLODOWSKIECURIE1
CHAIM SHEBA MEDICAL CENTER1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
COMPUGEN1
CONSEJERIA DE SALUD Y SERVICIOS SANITARIOS DEL PRINCIPADO DE ASTURIAS1
CONSEJERIA DE SALUD Y SERVICIOS SANITARIOS PRINCIPADO DE ASTURIAS1
CONSEJERIA DE SANIDAD DE LA REGION DE MURCIA1
Constancy:

Total number of partners:463

Partner loyalty:
Frequent Partner: (> 2 projects): 74
Rare Partner: 389

Frequent / Rare Partner Ratio: 0.19

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES21
RTD HORIZONTAL TOPICS12
SOCIAL AND ECONOMIC CONCERNS11
INDUSTRY AND TECHNOLOGY8
PROTECTING MAN AND HIS ENVIRON7
AGRICULTURE AND MARINE RESOURC4
ENERGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-02-01Molecule-to-man pain network PAIN-Netparticipant3.354.46510
2017-01-01SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine SPIDIA4Pparticipant1.999.97319
2016-05-01Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy PRECIOUSparticipant8.291.21811
2016-01-01Big Data and models for personalized Head and Neck Cancer Decision support BD2Decideparticipant4.845.00013
2013-10-01Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors REQUITEparticipant5.997.40815
2013-08-01Randomized controlled trial of metformin and dietary restriction to prevent age-related morbid events in people with metabolic syndrome MEMEMEparticipant2.500.0001
2012-03-01Determinants of eating behaviour in European children, adolescents and their parents I.Familyparticipant9.000.00017
2012-01-01Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China IMMUNOCANparticipant1.992.2145
2012-01-01EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations EPIC-CVDparticipant5.987.26630
2011-12-01European Clinical trials in Rare Sarcomas within an integrated translational trial network EUROSARCparticipant5.953.83218
2011-02-01Role and Modulation of Jak and STAT signaling in Graft Rejection and Graft versus Host Disease HSCT and Jak-STATcoordinator75.0001
2011-01-02Transfection Ability and Intracellular Pathway of LbL Nanostructured siRNA Delivery Systems Nanosirnacoordinator48.6003
2011-01-01Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNGparticipant2.965.74911
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2010-11-01Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMICparticipant2.999.47810
2010-05-01Three modality contrast imaging using multi-functionalized microballoons 3MICRONparticipant5.999.41210
2006-11-01Improved treatment of pain, depression and fatigue through translation research EPCRCparticipant2.799.91011
2006-10-01Systems for in-situ theranostics using micro-particles triggered by ultrasound S.I.G.H.T.participant2.599.99910
2006-03-01Cancer Immunology and Immunotherapy CANCERIMMUNOTHERAPYparticipant12.185.10224
2006-02-01CONnective TIssue CAncers NETwork to integrate European Experience in Adults and Children CONTICANETparticipant9.432.60021
2006-01-01Simulation modelling of the MAP kinase pathway SIMAPparticipant3.126.6619
2005-12-01European Prospective Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle EPICparticipant999.74527
2005-08-19Bio-molecular characterization of tumour stem cells and their use as targets of immune and pharmacological therapy TUMOR STEM CELLcoordinator76.6321
2005-04-01The impact of key determinants on the current and future burden of cancer in Europe EUROCADETparticipant987.96312
2004-10-01Developing Molecular Medicines for Cancer in the Post-Genome Era MOL CANCER MEDparticipant3.880.00015
2004-01-01Computational intelligence for Bio-pattern analysis in support of eHealthcare BIOPATTERNparticipant6.400.00030
2003-03-01Improving health through dietary phytoestrogens: a pan-european network on consumers' issues and opportunities for producers PHYTOHEALTHparticipant890.84844
2003-01-01Development of an innovative genotoxicity measuring device to facilitate the safety control in environmental applications GENO-SENSEparticipant397.1889
2002-11-01The use of molecular biomarkers in early lung cancer detection (EARLY LUNG CANCER) EARLY LUNG CANCERparticipant3.045.02515
2002-01-01European cooperation network to collect & disperse ethical, safety & regulatory data in order to facilitate clinical implementation of gene transfer technology (gene therapy) EUREGENETHY2participant760.00015
2001-03-01Case-only study on the interaction of diet and genetic predisposition in the occurrence of breast cancer in young women. C.O.S.coordinator970.6409
2001-01-01Dietary habit profile in european communites with different risk of myocardial infarction: the impact of migration as a model of gene/environment interaction IMMIDIETparticipant1.587.5437
2000-02-01Genetic mechanisms involving ultraviolet light in the development of cutaneous malignant melanoma MAUVEparticipant1.449.3158
2000-02-01Antigen presentation by chaperon proteins and cd4+ t cell specific help for a new and efficient strategy of cancer vaccination. NEW CANCER VACCINEScoordinator2.399.7298
2000-02-01Mechanisms and genetics of radiation induced tumorigenesis: mouse models of leukaemia, lymphoma and skin neoplasia MAGELLANSparticipant900.0004

Alias institution names:
  • ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum